Beyond Borders: Advancing Infectious Disease & Global Health

3PM – 4PM | Bornstein Amphitheatre

About the Session

Remember when the World Health Organization nearly canceled the Olympics to avoid spreading the Zika virus? That’s because emerging diseases like Zika pose a major threat both at home and abroad. BWH researchers and clinicians are hard at work investigating diseases like Zika, along with HIV, Ebola, West Nile, TB and others, in addition to treating patients in vulnerable areas of the world where the scarcity of resources, drugs and clinicians contribute increased disease transmission.

During this session, a panel of BWH global health experts will discuss their work at home and overseas, which is bringing us closer to developing vaccines.

Speakers


MODERATOR:

  • Apoorva Mandavilli
    Science Journalist, Editor-in-Chief, Spectrum

 

PANELISTS:

  • Daniel Kuritzkes, MD
    Chief, Division of Infectious Diseases, BWH
    Professor of Medicine, Harvard Medical School

 

  • Shahin Lockman, MD
    Associate Professor of Medicine, Harvard Medical School and BWH Division of Infectious Diseases, and Associate Professor in the Department of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health

 

  • Lisa Cosimi, MD
    Associate Physician, Divisions of Global Health Equity & Infectious Diseases, Brigham & Women’s Hospital
    Assistant Professor of Medicine, Harvard Medical School

 

  • James Rooney, MD
    Vice President, Medical Affairs, Gilead Sciences
cosimi

Lisa Cosimi, MD
Associate Physician, Divisions of Global Health Equity & Infectious Diseases, Brigham & Women’s Hospital
Assistant Professor of Medicine, Harvard Medical School

Dr. Cosimi is the Director of The Partnership for Health Advancement in Vietnam (HAIVN), a collaboration between Harvard Medical School (HMS), Brigham and Women’s Hospital (BWH), and Beth Israel Deaconess Medical Center (BIDMC).  In partnership with Vietnam’s Ministry of Health HAIVN’s mission is to improve the quality of medical education, research, and healthcare in Vietnam.  Dr. Cosimi has been working in Vietnam since 2003 and lived there from 2003-2007.  From 2005-2007, she served as chief of CDC-Vietnam’s care and treatment branch and supported the scale up of HIV treatment programs throughout Vietnam. Her areas of interest include developing and evaluating effective ways to provide sustainable medical education and improve healthcare quality in resource-limited settings. Dr. Cosimi received a B.A. in Economics from Cornell University in 1992 and M.D. from the Weill Cornell Medical College in 1996.  She completed her residency in Internal Medicine and Primary Care at the Massachusetts General Hospital and Infectious Disease training at the Partners combined fellowship program.

kuritzkes

Daniel R. Kuritzkes, MD
Chief, Division of Infectious Diseases, BWH
Professor of Medicine, Harvard Medical School

Dr. Kuritzkes is Professor of Medicine at Harvard Medical School & Chief of the Division of Infectious Diseases at BWH. He has published extensively on antiretroviral therapy & drug resistance in HIV-1 infection. He has also chaired several multicenter studies of HIV therapy & currently serves as Principal Investigator & Chair of the AIDS Clinical Trials Group. He is a member of the U.S. Department of Health & Human Services panel on guidelines for antiretroviral therapy & the NIH Office of AIDS Research Advisory Council, & previously served as Chair of the HIV Medicine Association Board of Directors. Dr. Kuritzkes has been a member of several editorial boards & serves an Associate Editor of the Journal of Infectious Diseases. His research interests focus on antiretroviral therapy, drug resistance, & HIV eradication. He received his B.S. & M.S. degrees from Yale University & his M.D. from Harvard Medical School.

shahin

Shahin Lockman, MD
Associate Professor of Medicine, Harvard Medical School and BWH Division of Infectious Diseases, and Associate Professor in the Department of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health

Dr. Lockman has led epidemiologic and clinical trials investigation related to HIV-1 and tuberculosis in Botswana since 1996, with a focus on optimizing antiretroviral treatment of pregnant and postpartum women with HIV and understanding and improving health and neurodevelopmental outcomes of HIV-exposed infants. In Botswana, she also co-leads the Botswana Clinical Trials Unit (which conducts multisite HIV-related trials), is co-PI of a community-randomized trial of community-based HIV-prevention interventions, and mentors investigators on clinical and programmatic research related to HIV and cancer/cardiovascular disease.

2

Apoorva Mandavilli
Science Journalist, Editor-in-Chief, Spectrum

Apoorva Mandavilli is an award-winning science journalist. She writes about infectious diseases, the brain, public health and policy. She is the founding editor and editor-in-chief of Spectrum, the leading source of autism news for scientists. Her work has also appeared in The New York TimesThe New Yorker online, The Atlantic, Slate, Nature and others.

jim-rooney-headshot

James F. Rooney, MD
Vice President, Medical Affairs

Dr. James F. Rooney joined Gilead Sciences in 1996 as Vice President of Clinical Research and in 2004 became Vice President of Medical Affairs.  From 2004 to 2006, he was also Vice President of Drug Safety and Public Health.  Dr. Rooney has been instrumental in the clinical development of the company’s antiviral therapies, including treatments for HIV, hepatitis B and influenza.  Dr. Rooney also leads many of the company’s clinical research activities in the developing world.

Prior to joining Gilead, Dr. Rooney worked as a global project leader in HIV at Burroughs Wellcome and Glaxo Wellcome.  Dr. Rooney received his undergraduate degree at Harvard University, in Cambridge, Massachusetts, his medical degree and residency training in Internal Medicine at the University of Maryland Hospital in Baltimore, Maryland, and his training in Infectious Diseases at the Laboratory of Clinical Investigation, National Institutes of Health, Bethesda, Maryland.  Dr. Rooney is board certified in Internal Medicine and Infectious Diseases and is a Fellow of the Infectious Diseases Society of America.